- Home
- PRTA vs DAVE Comparison
PRTA vs DAVE Comparison
Compare PRTA & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- DAVE
- Stock Information
- Founded
- PRTA 2012
- DAVE 2017
- Country
- PRTA Ireland
- DAVE United States
- Employees
- PRTA N/A
- DAVE N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- DAVE Retail: Computer Software & Peripheral Equipment
- Sector
- PRTA Health Care
- DAVE Technology
- Exchange
- PRTA Nasdaq
- DAVE Nasdaq
- Market Cap
- PRTA 802.8M
- DAVE 795.6M
- IPO Year
- PRTA N/A
- DAVE N/A
- Fundamental
- Price
- PRTA $13.41
- DAVE $102.27
- Analyst Decision
- PRTA Buy
- DAVE Strong Buy
- Analyst Count
- PRTA 7
- DAVE 6
- Target Price
- PRTA $57.67
- DAVE $96.50
- AVG Volume (30 Days)
- PRTA 448.2K
- DAVE 493.4K
- Earning Date
- PRTA 11-12-2024
- DAVE 11-12-2024
- Dividend Yield
- PRTA N/A
- DAVE N/A
- EPS Growth
- PRTA N/A
- DAVE N/A
- EPS
- PRTA N/A
- DAVE 3.12
- Revenue
- PRTA $133,350,000.00
- DAVE $319,355,000.00
- Revenue This Year
- PRTA $46.28
- DAVE $30.69
- Revenue Next Year
- PRTA N/A
- DAVE $20.47
- P/E Ratio
- PRTA N/A
- DAVE $33.33
- Revenue Growth
- PRTA N/A
- DAVE 30.00
- 52 Week Low
- PRTA $12.31
- DAVE $7.73
- 52 Week High
- PRTA $41.55
- DAVE $108.50
- Technical
- Relative Strength Index (RSI)
- PRTA 43.50
- DAVE 70.23
- Support Level
- PRTA $12.31
- DAVE $82.18
- Resistance Level
- PRTA $14.28
- DAVE $108.50
- Average True Range (ATR)
- PRTA 0.98
- DAVE 8.46
- MACD
- PRTA 0.00
- DAVE 0.13
- Stochastic Oscillator
- PRTA 33.73
- DAVE 83.49
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.